filings.toolsItem 16. Form 10-K Summary
4K characters. Original on sec.gov · Markdown
Item 16. Form 10-K Summary
Not applicable.
SCHEDULE II
AMPHENOL CORPORATION AND SUBSIDIARIES
VALUATION AND QUALIFYING ACCOUNTS
For the years ended December 31, 2025, 2024 and 2023
(Dollars in millions)
| | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | | Balance at | | Charged to | | | | | Balance at | ||||
| | | beginning | | cost and | | Additions | | end of | |||||
| | | of period | | expenses | | (Deductions) | | period | |||||
| Allowance for doubtful accounts: | | | | | | | | | | | | | |
| Year ended December 31, 2025 | | $ | 66.5 | | $ | 35.4 | | $ | (2.6) | | $ | 99.3 | |
| Year ended December 31, 2024 | | 68.4 | | | 2.6 | | | (4.5) | | | 66.5 | | |
| Year ended December 31, 2023 | | 63.9 | | | 13.4 | | | (8.9) | | 68.4 | | ||
| | | | | | | | | | | | | | |
| Valuation allowance on deferred tax assets: | | | | | | | | | | | | | |
| Year ended December 31, 2025 | | $ | 73.6 | | $ | 2.6 | | $ | 11.4 | | $ | 87.6 | |
| Year ended December 31, 2024 | | | 46.6 | | | 10.8 | | | 16.2 | | | 73.6 | |
| Year ended December 31, 2023 | | 42.2 | | | 3.4 | | | 1.0 | | | 46.6 | |
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized in the Town of Wallingford, State of Connecticut on the 11th day of February, 2026.
| | |
|---|---|
| | AMPHENOL CORPORATION |
| | |
| | |
| | /s/ R. Adam Norwitt |
| | R. Adam Norwitt |
| | President and Chief Executive Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| | | |||
|---|---|---|---|---|
| Signature | | Title | | Date |
| | | | | |
| | | | | |
| /s/ R. Adam Norwitt | | President, Chief Executive Officer and Director | | February 11, 2026 |
| R. Adam Norwitt | | (Principal Executive Officer) | | |
| | | | | |
| /s/ Craig A. Lampo | | Executive Vice President and Chief Financial Officer | | February 11, 2026 |
| Craig A. Lampo | | (Principal Financial Officer) | | |
| | | | | |
| /s/ Michael R. Ivas | | Senior Vice President and Corporate Controller | | February 11, 2026 |
| Michael R. Ivas | | (Principal Accounting Officer) | | |
| | | | | |
| /s/ Martin H. Loeffler | | Chairman of the Board of Directors | | February 11, 2026 |
| Martin H. Loeffler | | | | |
| | | | | |
| /s/ David P. Falck | | Presiding Director | | February 11, 2026 |
| David P. Falck | | | | |
| | | | | |
| /s/ Nancy A. Altobello | | Director | | February 11, 2026 |
| Nancy A. Altobello | | | | |
| | | | | |
| /s/ Rita S. Lane | | Director | | February 11, 2026 |
| Rita S. Lane | | | | |
| | | | | |
| /s/ Robert A. Livingston | | Director | | February 11, 2026 |
| Robert A. Livingston | | | | |
| | | | | |
| /s/ Prahlad Singh | | Director | | February 11, 2026 |
| Prahlad Singh | | | | |
| | | | | |
| /s/ Anne Clarke Wolff | | Director | | February 11, 2026 |
| Anne Clarke Wolff | | | | |
Previous: Item 15. Exhibits and Financial Statement Schedules